Business Context and Reporting Period
PMGC Holdings Inc. (formerly ElevaiLabs Inc.) filed this Form 8-K on December 23, 2024, reporting an event dated December 31, 2024. The Company, through its wholly owned subsidiary Elevai Skincare Inc., entered into an Asset Purchase Agreement to sell substantially all assets related to its skincare and haircare business to Cutis Cura Corporation (Cutis) and its parent, Carmell Corporation.
Key Financial Metrics and Transaction Terms
The filing details a divestiture transaction rather than standard operating financial results. Key financial terms include:
- Stock Consideration: Cutis/Carmell will issue shares of Carmell common stock with an aggregate market value of $1,075,463.
- Holdback: $100,000 of the stock consideration will be withheld for 12 months to secure indemnification obligations.
- Cash Consideration (Product Sale): $56,525 payable within 60 days following the sale of specific inventory units (7,500 Enfinity units and 20,000 Empower tubes).
- Liabilities: Cutis will assume specific trade accounts payable and obligations under assigned contracts incurred in the ordinary course of business. All other liabilities are excluded.
Material Changes and Future Obligations
The primary material change is the divestiture of the Company's core skincare and haircare business assets. Future financial obligations and potential inflows include:
- Royalty Payments: Cutis must pay 5% of Net Sales generated from existing products for five years following the Closing Date.
- Milestone Payment: A one-time payment of $500,000 is due if Cutis achieves $500,000 in net revenue from existing hair and scalp products within 24 months of Closing.
- Earnout: Additional earnout payments may be payable pursuant to Section 2.05 of the agreement.
Guidance, Outlook, and Risks
The filing does not provide specific financial guidance, revenue forecasts, or management commentary regarding future operational outlook beyond the transaction terms. The transaction is subject to customary conditions precedent, and the Closing Date is to be mutually agreed upon, no later than the second business day after conditions are satisfied. Risks include the failure to satisfy closing conditions and the uncertainty of future earnout or milestone payments.
Investor Verification Checklist
- Verify the final Closing Date and whether all conditions precedent were satisfied.
- Confirm the exact number of Carmell shares issued and the market value calculation at Closing.
- Monitor the sale of the specified Enfinity and Empower inventory units to trigger the $56,525 cash payment.
- Track Cutis's future Form 10-K filings to verify the 5% royalty payments on Net Sales.
- Assess whether the $500,000 revenue milestone for hair and scalp products is met within the 24-month window.